ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market - Global Outlook and Forecast 2023-2027

Report ID: 697730 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Overall Market Size
    2.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size: 2021 VS 2027
    2.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Players in Global Market
    3.2 Top Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Companies Ranked by Revenue
    3.3 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue by Companies
    3.4 Top 3 and Top 5 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Companies in Global Market, by Revenue in 2020
    3.5 Global Companies ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Type
    3.6 Tier 1, Tier 2 and Tier 3 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Players in Global Market
        3.6.1 List of Global Tier 1 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Companies
        3.6.2 List of Global Tier 2 and Tier 3 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Markets, 2021 & 2027
        4.1.2 Crizotinib
        4.1.3 Alectinib
        4.1.4 Ceritinib
        4.1.5 Brigatinib
        4.1.6 Lorlatinib
        4.1.7 Ensartinib
        4.1.8 CT-707
    4.2 By Type - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue & Forecasts
        4.2.1 By Type - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, 2016-2021
        4.2.2 By Type - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, 2022-2027
        4.2.3 By Type - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2021 & 2027
        5.1.2 Leukemia
        5.1.3 Solid Tumor
        5.1.4 Lung Cancer
        5.1.5 Others
    5.2 By Application - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue & Forecasts
        5.2.1 By Application - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, 2016-2021
        5.2.2 By Application - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, 2022-2027
        5.2.3 By Application - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2021 & 2027
    6.2 By Region - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue & Forecasts
        6.2.1 By Region - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, 2016-2021
        6.2.2 By Region - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, 2022-2027
        6.2.3 By Region - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, 2016-2027
        6.3.2 US ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
        6.3.3 Canada ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
        6.3.4 Mexico ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, 2016-2027
        6.4.2 Germany ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
        6.4.3 France ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
        6.4.4 U.K. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
        6.4.5 Italy ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
        6.4.6 Russia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
        6.4.7 Nordic Countries ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
        6.4.8 Benelux ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, 2016-2027
        6.5.2 China ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
        6.5.3 Japan ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
        6.5.4 South Korea ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
        6.5.5 Southeast Asia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
        6.5.6 India ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, 2016-2027
        6.6.2 Brazil ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
        6.6.3 Argentina ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, 2016-2027
        6.7.2 Turkey ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
        6.7.3 Israel ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
        6.7.4 Saudi Arabia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
        6.7.5 UAE ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, 2016-2027
7 Players Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporate Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Major Product Offerings
        7.1.4 Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue in Global (2016-2021)
        7.1.5 Pfizer Key News
    7.2 Nuvartis
        7.2.1 Nuvartis Corporate Summary
        7.2.2 Nuvartis Business Overview
        7.2.3 Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Major Product Offerings
        7.2.4 Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue in Global (2016-2021)
        7.2.5 Nuvartis Key News
    7.3 Takeda
        7.3.1 Takeda Corporate Summary
        7.3.2 Takeda Business Overview
        7.3.3 Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Major Product Offerings
        7.3.4 Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue in Global (2016-2021)
        7.3.5 Takeda Key News
    7.4 Betta Pharma
        7.4.1 Betta Pharma Corporate Summary
        7.4.2 Betta Pharma Business Overview
        7.4.3 Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Major Product Offerings
        7.4.4 Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue in Global (2016-2021)
        7.4.5 Betta Pharma Key News
    7.5 Shouyao Holding
        7.5.1 Shouyao Holding Corporate Summary
        7.5.2 Shouyao Holding Business Overview
        7.5.3 Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Major Product Offerings
        7.5.4 Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue in Global (2016-2021)
        7.5.5 Shouyao Holding Key News
    7.6 Chugai Pharmaceutical Co
        7.6.1 Chugai Pharmaceutical Co Corporate Summary
        7.6.2 Chugai Pharmaceutical Co Business Overview
        7.6.3 Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Major Product Offerings
        7.6.4 Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue in Global (2016-2021)
        7.6.5 Chugai Pharmaceutical Co Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Opportunities & Trends in Global Market
    Table 2. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Drivers in Global Market
    Table 3. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Restraints in Global Market
    Table 4. Key Players of ALK Tyrosine Kinase Inhibitors (ALK-TKIs) in Global Market
    Table 5. Top ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Players in Global Market, Ranking by Revenue (2019)
    Table 6. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Share by Companies, 2016-2021
    Table 8. Global Companies ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Type
    Table 9. List of Global Tier 1 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2021 VS 2027
    Table 12. By Type - ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue in Global (US$, Mn), 2016-2021
    Table 13. By Type - ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue in Global (US$, Mn), 2022-2027
    Table 14. By Application – Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue in Global (US$, Mn), 2016-2021
    Table 16. By Application - ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue in Global (US$, Mn), 2022-2027
    Table 17. By Region – Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2021 VS 2027
    Table 18. By Region - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue (US$, Mn), 2016-2021
    Table 19. By Region - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue (US$, Mn), 2022-2027
    Table 20. By Country - North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2021
    Table 21. By Country - North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2022-2027
    Table 22. By Country - Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2021
    Table 23. By Country - Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2022-2027
    Table 24. By Region - Asia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2021
    Table 25. By Region - Asia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2022-2027
    Table 26. By Country - South America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2021
    Table 27. By Country - South America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2022-2027
    Table 28. By Country - Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2021
    Table 29. By Country - Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2022-2027
    Table 30. Pfizer Corporate Summary
    Table 31. Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offerings
    Table 32. Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue (US$, Mn), (2016-2021)
    Table 33. Nuvartis Corporate Summary
    Table 34. Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offerings
    Table 35. Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue (US$, Mn), (2016-2021)
    Table 36. Takeda Corporate Summary
    Table 37. Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offerings
    Table 38. Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue (US$, Mn), (2016-2021)
    Table 39. Betta Pharma Corporate Summary
    Table 40. Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offerings
    Table 41. Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue (US$, Mn), (2016-2021)
    Table 42. Shouyao Holding Corporate Summary
    Table 43. Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offerings
    Table 44. Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue (US$, Mn), (2016-2021)
    Table 45. Chugai Pharmaceutical Co Corporate Summary
    Table 46. Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offerings
    Table 47. Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue (US$, Mn), (2016-2021)
List of Figures
    Figure 1. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Segment by Type
    Figure 2. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Segment by Application
    Figure 3. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, 2016-2027 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue in 2020
    Figure 8. By Type - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share, 2016-2027
    Figure 9. By Application - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share, 2016-2027
    Figure 10. By Region - Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share, 2016-2027
    Figure 11. By Country - North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share, 2016-2027
    Figure 12. US ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 13. Canada ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 14. Mexico ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 15. By Country - Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share, 2016-2027
    Figure 16. Germany ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 17. France ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 18. U.K. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 19. Italy ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 20. Russia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 21. Nordic Countries ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 22. Benelux ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 23. By Region - Asia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share, 2016-2027
    Figure 24. China ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 25. Japan ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 26. South Korea ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 27. Southeast Asia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 28. India ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 29. By Country - South America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share, 2016-2027
    Figure 30. Brazil ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 31. Argentina ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 32. By Country - Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share, 2016-2027
    Figure 33. Turkey ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 34. Israel ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 35. Saudi Arabia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 36. UAE ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, (US$, Mn), 2016-2027
    Figure 37. Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 38. Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 39. Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 40. Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 41. Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 42. Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
ALK Tyrosine Kinase Inhibitors Market In Pharma & Healthcare report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
ALK Tyrosine Kinase Inhibitors Market In Pharma & Healthcare report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
ALK Tyrosine Kinase Inhibitors Market In Pharma & Healthcare report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports